Test Catalog

Test ID: HCVDR    
Hepatitis C Virus Genotypic Antiviral Drug Resistance, Serum

Fees Several factors determine the fee charged to perform a test. Contact your U.S. or International Regional Manager for information about establishing a fee schedule or to learn more about resources to optimize test selection.

  • Authorized users can sign in to Test Prices for detailed fee information.
  • Clients without access to Test Prices can contact Customer Service 24 hours a day, seven days a week.
  • Prospective clients should contact their Regional Manager. For assistance, contact Customer Service.

Test Classification Provides information regarding the medical device classification for laboratory test kits and reagents. Tests may be classified as cleared or approved by the US Food and Drug Administration (FDA) and used per manufacturer instructions, or as products that do not undergo full FDA review and approval, and are then labeled as an Analyte Specific Reagent (ASR) product.

This test was developed and its performance characteristics determined by Mayo Clinic in a manner consistent with CLIA requirements. This test has not been cleared or approved by the U.S. Food and Drug Administration.

CPT Code Information Provides guidance in determining the appropriate Current Procedural Terminology (CPT) code(s) information for each test or profile. The listed CPT codes reflect Mayo Clinic Laboratories interpretation of CPT coding requirements. It is the responsibility of each laboratory to determine correct CPT codes to use for billing.

CPT codes are provided by the performing laboratory.

87900

87902

LOINC® Information Provides guidance in determining the Logical Observation Identifiers Names and Codes (LOINC) values for the order and results codes of this test. LOINC values are provided by the performing laboratory.

Test IDTest Order NameOrder LOINC Value
HCVDRHCV Genotypic Drug Resistance, S82525-7

 

Result IDTest Result NameResult LOINC ValueApplies only to results expressed in units of measure originally reported by the performing laboratory. These values do not apply to results that are converted to other units of measure.
604410HCV Genotypic Drug Resistance, S77202-0
604376HCV Genotype92731-9
604377HCV NS3 RAS73654-6
604378Sequence failure at codons:92732-7
604379Glecaprevir resistance92733-5
604380Grazoprevir resistance82523-2
604382Voxilaprevir resistance92734-3
604383HCV NS5A RAS73655-3
604384Sequence failure at codons:92732-7
604385Daclatasvir resistance82379-9
604386Elbasvir resistance82376-5
604387Ledipasvir resistance82377-3
604388Pibrentasvir resistance92735-0
604389Velpatasvir resistance82520-8
604390HCV NS5B RAS73655-3
604391Sequence failure at codons:92732-7
604392Sofosbuvir resistance82382-3
604393HCV Genotype92731-9
604394HCV NS3 RAS73654-6
604395Sequence failure at codons:92732-7
604396Glecaprevir resistance92733-5
604397Grazoprevir resistance82523-2
604399Voxilaprevir resistance92734-3
604400HCV NS5A RAS73655-3
604401Sequence failure at codons:92732-7
604402Daclatasvir resistance82379-9
604403Elbasvir resistance82376-5
604404Ledipasvir resistance82377-3
604405Pibrentasvir resistance92735-0
604406Velpatasvir resistance82520-8
604407HCV NS5B RAS73655-3
604408Sequence failure at codons:92732-7
604409Sofosbuvir resistance82382-3
HCRVLRecent HCV quant over 50,000 IU/mL?86955-2
HCVKGIs known HCV genotype 1a, 1b, or 3?86955-2